mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.6 |